GENOMIC HEALTH INC's ticker is GHDX and the CUSIP is 37244C101. A total of 106 filers reported holding GENOMIC HEALTH INC in Q3 2014. The put-call ratio across all filers is 1.50 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $519,000 | -7.7% | 15,951 | -10.7% | 0.22% | +10.8% |
| Q1 2017 | $562,000 | +11.1% | 17,855 | +3.6% | 0.19% | +16.9% |
| Q4 2016 | $506,000 | +0.4% | 17,230 | -1.1% | 0.17% | +5.1% |
| Q3 2016 | $504,000 | +10.5% | 17,415 | -1.0% | 0.16% | +9.7% |
| Q2 2016 | $456,000 | +61.7% | 17,595 | +54.5% | 0.14% | +82.3% |
| Q1 2016 | $282,000 | -29.0% | 11,385 | +0.8% | 0.08% | -33.1% |
| Q4 2015 | $397,000 | -13.9% | 11,290 | -48.1% | 0.12% | +18.0% |
| Q3 2015 | $461,000 | -10.3% | 21,765 | +17.7% | 0.10% | -2.9% |
| Q2 2015 | $514,000 | +19.0% | 18,490 | +30.6% | 0.10% | +17.0% |
| Q1 2015 | $432,000 | -8.5% | 14,155 | -4.1% | 0.09% | -7.4% |
| Q4 2014 | $472,000 | +155.1% | 14,765 | +125.9% | 0.10% | +90.0% |
| Q3 2014 | $185,000 | +6.9% | 6,535 | +3.5% | 0.05% | +4.2% |
| Q2 2014 | $173,000 | – | 6,315 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 11,744,010 | $756,432,000 | 6.19% |
| EMORY UNIVERSITY | 30,319 | $1,953,000 | 1.54% |
| Copper Rock Capital Partners, LLC | 292,596 | $18,630,000 | 1.46% |
| DE BURLO GROUP INC | 73,600 | $4,740,000 | 1.06% |
| Eversept Partners, LP | 23,866 | $1,537,209 | 0.83% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 165,310 | $10,648,000 | 0.83% |
| Aurora Investment Counsel | 20,916 | $1,347,000 | 0.73% |
| Texas Children's | 8,035 | $518,000 | 0.72% |
| Capital Impact Advisors, LLC | 24,665 | $1,570,000 | 0.67% |
| Granahan Investment Management | 130,650 | $8,415,000 | 0.60% |